相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High-Dose Chloroquine for Uncomplicated Plasmodium falciparum Malaria Is Well Tolerated and Causes Similar QT Interval Prolongation as Standard-Dose Chloroquine in Children
Johan Ursing et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Of chloroquine and COVID-19
Franck Touret et al.
ANTIVIRAL RESEARCH (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Jianjun Gao et al.
BIOSCIENCE TRENDS (2020)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)
Riccardo M. Inciardi et al.
JAMA CARDIOLOGY (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
Antimalarial drugs and their metabolites are potent Zika virus inhibitors
Yingshan Han et al.
JOURNAL OF MEDICAL VIROLOGY (2019)
Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses
Joe-Ann S. Moser et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2019)
A social network analysis on immigrants and refugees access to services in the malaria elimination context
Ensiyeh Jamshidi et al.
MALARIA JOURNAL (2019)
Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters
Cornelis Smit et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2018)
High-Dose Chloroquine for Treatment of Chloroquine-Resistant Plasmodium falciparum Malaria
Johan Ursing et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Inflammation and Organ Failure Severely Affect Midazolam Clearance in Critically Ill Children
Nienke J. Vet et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Population pharmacokinetics of a three-day chloroquine treatment in patients with Plasmodium vivax infection on the Thai-Myanmar border
Richard Hoeglund et al.
MALARIA JOURNAL (2016)
Drug Disposition in Obesity: Toward Evidence-Based Dosing
Catherijne A. J. Knibbe et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Strategic roles for behaviour change communication in a changing malaria landscape
Hannah Koenker et al.
MALARIA JOURNAL (2014)
Drug absorption, distribution, metabolism and excretion considerations in critically ill adults
Derek J. Roberts et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
The Relationship between Drug Clearance and Body Size Systematic Review and Meta-Analysis of the Literature Published from 2000 to 2007
Sarah C. McLeay et al.
CLINICAL PHARMACOKINETICS (2012)
Population Pharmacokinetics and Pharmacodynamics of Propofol in Morbidly Obese Patients
Simone van Kralingen et al.
CLINICAL PHARMACOKINETICS (2011)
Population pharmacokinetics of chloroquine and sulfadoxine and treatment response in children with malaria: suggestions for an improved dose regimen
Celestino Obua et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
The Operational Multiple Dosing Half-life: A Key to Defining Drug Accumulation in Patients and to Designing Extended Release Dosage Forms
Selma Sahin et al.
PHARMACEUTICAL RESEARCH (2008)
Tissue concentrations: do we ever learn?
Johan W. Mouton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Real-time quantitative PCR with SYBR Green I detection for estimating copy numbers of nine drug resistance candidate genes in Plasmodium falciparum -: art. no. 1
ID Ferreira et al.
MALARIA JOURNAL (2006)
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent et al.
VIROLOGY JOURNAL (2005)
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
E Keyaerts et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Issues in pharmacokinetics and pharmacodynamics of anti-infective agents:: Distribution in tissue
M Müller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Cytochrome P4502C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes
KA Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2003)
Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs
DR Brocks et al.
CLINICAL PHARMACOKINETICS (2003)
分享论文
